Also available in Persian — نسخه فارسی EN فا
❓ Unknown

GLP-1 Drugs Linked to Increased Regurgitation Risk During Anesthesia

Just now September 17, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Recent research indicates that patients using GLP-1 receptor agonists experience an 11-fold increase in regurgitation rates during anesthesia compared to those not using these medications. This finding was presented at a medical conference in the UK and published in a medical journal. While the absolute risk remains low, it raises concerns about the safety of these drugs, which could impact healthcare practices in Iran.

🔍 Quick Context Guide
💡 Bottom Line: The study raises important safety concerns regarding GLP-1 medications during surgical procedures.

👥 Key Players

Association of Anaesthetists MENTIONED
Professional organization for anesthetists
"They provide guidelines and research that influence medical practices, including those in Iran."
Researchers presenting the study MENTIONED
Medical researchers
"Their findings can impact the safety protocols for medications used in surgeries, affecting patient care in Iran."

📰 What Happened

New research has revealed that patients taking GLP-1 receptor agonists experience a significantly higher rate of regurgitation during anesthesia. This finding was presented at a medical conference and published in a medical journal.

  • Regurgitation rates are 11 times higher in patients taking GLP-1 RAs during anesthesia.
  • The absolute risk of regurgitation remains low despite the increased rate.

💡 Why It Matters

🇮🇷 For Iran: This research could lead to changes in how GLP-1 medications are prescribed and monitored in Iran, impacting patient safety.
🌍 Regional: Countries in the region may also reconsider the use of GLP-1 medications based on these findings.
🌐 International: The findings may prompt further scrutiny of GLP-1 medications globally, affecting their market and usage.

📚 Background

GLP-1 receptor agonists are a class of drugs used to treat diabetes and obesity, but their safety during anesthesia is now under question.

Diabetes treatment Anesthesia safety
📡 Source: NEUTRAL
📊 Confidence: 70%
The information is based on research presented at a reputable medical conference and published in a peer-reviewed journal.

New research presented at the Association of Anaesthetists Annual Meeting in Liverpool, UK (Sept. 16–18), and published in the journal Anaesthesia, shows that among patients undergoing surgical procedures under the care of an anesthetist, the rate of a complication known as regurgitation is 11 times higher among patients taking the new class of diabetes and obesity medications glucagon-like peptide-1 receptor agonists (GLP-1 RAs) than among patients not taking those drugs—although the absolute risk of this complication remains small.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →